Australia's Incannex jumps on $93 mln takeover deal
24/03/2022 11:33
** U.S.-listed shares of Australian medical cannabinoid co
Incannex Healthcare Ltd IXHL.O were up 17.15% at $13.80
premarket
** Co after market close on Wednesday proposed to buy
Netherlands-based biopharma co APIRx Pharmaceuticals USA LLC in
an all-stock deal valued at about $93 mln [Full Story https://apac1-apps.platform.refinitiv.com/web/Apps/AdvFilings/#/view/66728605/default/docId
]
** APIRx will be entitled to nominate one board member to
Incannex
** IXHL down 21% since its Nasdaq debut earlier this month
(Reporting by Reshma Rockie George)
((Reshma.George@thomsonreuters.com))
Recent news on Incannex Healthcare
See all newsBrief: Incannex Healthcare Says Computershare To Be Appointed As US Transfer Agent
Brief: Incannex Healthcare Says Federal Court Of Australia Approved Proposed Schemes Of Arrangement Between Incannex And Its Shareholders
Australia's Incannex up as shareholders in favour of US redomicile
Brief: Incannex Healthcare Will Prepare FDA Ind Application PSI-Gad
Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed